Advanced SearchSearch Tips
GATA4 negatively regulates bone sialoprotein expression in osteoblasts
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 49, Issue 6,  2016, pp.343-348
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2016.49.6.032
 Title & Authors
GATA4 negatively regulates bone sialoprotein expression in osteoblasts
Song, Insun; Jeong, Byung-chul; Choi, Yong Jun; Chung, Yoon-Sok; Kim, Nacksung;
  PDF(new window)
GATA4 has been reported to act as a negative regulator in osteoblast differentiation by inhibiting the Dlx5 transactivation of Runx2 via the attenuation of the binding ability of Dlx5 to the Runx2 promoter region. Here, we determine the role of GATA4 in the regulation of bone sialoprotein (Bsp) in osteoblasts. We observed that the overexpression of Runx2 or Sox9 induced the Bsp expression in osteoblastic cells. Silencing GATA4 further enhanced the Runx2- and Sox9-mediated Bsp promoter activity, whereas GATA4 overexpression down-regulated Bsp promoter activity mediated by Runx2 and Sox9. GATA4 also interacted with Runx2 and Sox9, by attenuating the binding ability of Runx2 and Sox9 to the Bsp promoter region. Our data suggest that GATA4 acts as a negative regulator of Bsp expression in osteoblasts.
Bone sialoprotein;GATA4;Gene regulation;Runx2;Sox9;
 Cited by
Kim JH and Kim N (2016) Signaling pathways in osteoclast differentiation. Chonnam Med J 52, 12-17 crossref(new window)

Walsh MC, Kim N, Kadono Y et al (2006) Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24, 33-63 crossref(new window)

Komori T, Yagi H, Nomura S et al (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 crossref(new window)

Otto F, Thornell AP, Crompton T et al (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 crossref(new window)

Lee B, Thirunavukkarasu K, Zhou L et al (1997) Missense mutations abolishing DNA binding of the osteoblastspecific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet 16, 307-310 crossref(new window)

Hong JH, Hwang ES, McManus MT et al (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074-1078 crossref(new window)

Lee MH, Kim YJ, Yoon WJ et al (2005) Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280, 35579-35587 crossref(new window)

Zhou G, Zheng Q, Engin F et al (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci U S A 103, 19004-19009 crossref(new window)

Marie PJ (2008) Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 473, 98-105 crossref(new window)

Gubbay J, Koopman P, Collignon J, Burgoyne P and Lovell-Badge R (1990) Normal structure and expression of Zfy genes in XY female mice mutant in Tdy. Development 109, 647-653

Jo A, Denduluri S, Zhang B et al (2014) The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis 1, 149-161 crossref(new window)

Ikeda T, Kamekura S, Mabuchi A et al (2004) The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50, 3561-3573 crossref(new window)

Molkentin JD (2000) The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 275, 38949-38952 crossref(new window)

Viger RS, Guittot SM, Anttonen M, Wilson DB and Heikinheimo M (2008) Role of the GATA family of transcription factors in endocrine development, function, and disease. Mol Endocrinol 22, 781-798 crossref(new window)

Pikkarainen S, Tokola H, Kerkela R and Ruskoaho H (2004) GATA transcription factors in the developing and adult heart. Cardiovasc Res 63, 196-207 crossref(new window)

Foster BL, Soenjaya Y, Nociti FH Jr et al (2013) Deficiency in acellular cementum and periodontal attachment in bsp null mice. J Dent Res 92, 166-172 crossref(new window)

Ganss B, Kim RH and Sodek J (1999) Bone silaoprotein. Crit Rev Oral Biol Med 10, 79-98 crossref(new window)

Fisher LW and Fedarko NS (2003) Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 44, 33-40 crossref(new window)

Hunter GK and Goldberg HA (1994) Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 302, 175-179 crossref(new window)

Malaval L, Wade-Guéye NM and Boudiffa M et al (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205, 1145-1153 crossref(new window)

Barnes GL, Javed A, Waller SM et al (2003) Osteoblastrelated transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63, 2631-2637

Song I, Kim K, Kim JH et al (2014) GATA4 negatively regulates osteoblast differentiation by downregulation of Runx2. BMB Rep 47, 463-468 crossref(new window)

Hu L, Su P, Li R et al (2015) Knockdown of microtubule actin crosslinking factor 1 inhibits cell proliferation in MC3T3-E1 osteoblastic cells. BMB Rep 48, 583-588 crossref(new window)

Kim K, Kim JH, Lee J et al (2005) Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis. J Biol Chem 280, 35209-35216 crossref(new window)